152 related articles for article (PubMed ID: 9059132)
1. Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing.
Masi AT; Chrousos GP
Ann Rheum Dis; 1997 Jan; 56(1):1-4. PubMed ID: 9059132
[No Abstract] [Full Text] [Related]
2. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid use in rheumatoid arthritis.
Harris ED
Hosp Pract (Off Ed); 1983 Sep; 18(9):137-41, 145-6. PubMed ID: 6411587
[TBL] [Abstract][Full Text] [Related]
4. I have rheumatoid arthritis and was told that steroid injections can control my inflammation. Steroids also can be taken orally. Which is most effective?
Duke Med Health News; 2009 Mar; 15(3):12. PubMed ID: 19367769
[No Abstract] [Full Text] [Related]
5. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study.
Aviña-Zubieta JA; Abrahamowicz M; Choi HK; Rahman MM; Sylvestre MP; Esdaile JM; Lacaille D
Ann Rheum Dis; 2011 Jun; 70(6):990-5. PubMed ID: 21367762
[TBL] [Abstract][Full Text] [Related]
6. Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis.
Augustsson J; Eksborg S; Ernestam S; Gullström E; van Vollenhoven R
Ann Rheum Dis; 2007 Nov; 66(11):1462-6. PubMed ID: 17502359
[TBL] [Abstract][Full Text] [Related]
7. We still don't know how to taper glucocorticoids in rheumatoid arthritis, and we can do better.
Volkmann ER; Rezai S; Tarp S; Woodworth TG; Furst DE
J Rheumatol; 2013 Oct; 40(10):1646-9. PubMed ID: 24085754
[No Abstract] [Full Text] [Related]
8. Glucocorticoids in early rheumatoid arthritis.
Davey M; Buchbinder R
Aust Fam Physician; 2008; 37(1-2):31-2. PubMed ID: 18239749
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
[No Abstract] [Full Text] [Related]
10. Morning glucocorticoids versus night glucocorticoids: the role of low-dose glucocorticoid chronotherapy in rheumatoid arthritis.
Giangreco D; Cutolo M
J Clin Rheumatol; 2014 Dec; 20(8):437-9. PubMed ID: 25417681
[No Abstract] [Full Text] [Related]
11. Opposing effects of rheumatoid arthritis and low dose prednisolone on arginine metabolomics.
Radhakutty A; Mangelsdorf BL; Drake SM; Rowland A; Smith MD; Mangoni AA; Thompson CH; Burt MG
Atherosclerosis; 2017 Nov; 266():190-195. PubMed ID: 29035782
[TBL] [Abstract][Full Text] [Related]
12. Systemic glucocorticoid treatment in rheumatoid arthritis--a debate.
Kirwan JR; Russell AS
Scand J Rheumatol; 1998; 27(4):247-51. PubMed ID: 9751463
[TBL] [Abstract][Full Text] [Related]
13. Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking.
Wallace BI; Wallace DM; Waljee AK; Clauw DJ
Ann Rheum Dis; 2019 Dec; 78(12):1733-1734. PubMed ID: 31366468
[No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis--a neuroendocrine immune disorder: glucocorticoid resistance, relative glucocorticoid deficiency, low-dose glucocorticoid therapy, and insulin resistance.
Straub RH
Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):I1. PubMed ID: 25611004
[No Abstract] [Full Text] [Related]
15. Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.
Shimizu Y; Tanaka E; Inoue E; Shidara K; Sugimoto N; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H
Mod Rheumatol; 2018 May; 28(3):461-467. PubMed ID: 28880684
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.
Black RJ; Lester S; Buchbinder R; Barrett C; Lassere M; March L; Whittle S; Hill CL
Arthritis Res Ther; 2017 Nov; 19(1):253. PubMed ID: 29141677
[TBL] [Abstract][Full Text] [Related]
17. Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?
Buttgereit F; Burmester G; Bijlsma JW
Ann Rheum Dis; 2005 Jan; 64(1):171-2; author reply 172. PubMed ID: 15608329
[No Abstract] [Full Text] [Related]
18. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
Da Silva JA; Jacobs JW; Kirwan JR; Boers M; Saag KG; Inês LB; de Koning EJ; Buttgereit F; Cutolo M; Capell H; Rau R; Bijlsma JW
Ann Rheum Dis; 2006 Mar; 65(3):285-93. PubMed ID: 16107513
[TBL] [Abstract][Full Text] [Related]
19. Low dose prednisolone and insulin sensitivity differentially affect arterial stiffness and endothelial function: An open interventional and cross-sectional study.
Petersons CJ; Mangelsdorf BL; Poljak A; Smith MD; Greenfield JR; Thompson CH; Burt MG
Atherosclerosis; 2017 Mar; 258():34-39. PubMed ID: 28189039
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients.
Schroeder LL; Tang X; Wasko MC; Bili A
Rheumatol Int; 2015 Jun; 35(6):1059-67. PubMed ID: 25540049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
